Satisfaction and subjective symptoms after instillation of tafluprost or travoprost for twelve weeks each

Tomomi Nakamura, Takashi Kanamoto, Naoki Komatsu, Masaki Tanito, Shinichiro Teranishi, Tomoko Naito, Tetsuya Baba, Kazuyuki Hirooka, Shiro Mizoue, Yoshiaki Kiuchi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose : To report satisfaction and subjective symptoms after instillation of tafluprost followed by travoprost, or vice versa, for 12 weeks each. Cases and Method : This prospective study was made by 29 institutions including 7 universities. We evaluated 174 eyes of 174 cases after eliminating 21 eyes out of 195 cases. The series comprised 71 males and 103 females. The age ranged from 38 to 94 years, average 70 years. There were 167 cases of primary open-angle glaucoma and 7 cases of ocular hypertension. The cases were randomly divided into 2 groups. One group received instillation of 0.0015% tafluprost for 2 weeks and then instillation of 0.004% travoprost for 2 weeks. The other group received travoprost followed by travoprost for 2 weeks each. Satisfaction and subjective symptoms were evaluated by questionnaire. Results : There was no difference in subjective symptoms between tafluprost and travoprost. Tafluprost was significantly preferred over travoprost regarding satisfaction, presumably due to difference in the shape of commercially available ophthalmic solution. Conclusion : No difference was present between tafluprost and travoprost regarding subjective symptoms. Tafluprost was favored by the majority of patients.

Original languageEnglish
Pages (from-to)959-966
Number of pages8
JournalJapanese Journal of Clinical Ophthalmology
Volume68
Issue number7
Publication statusPublished - 2014

Fingerprint

Ocular Hypertension
Ophthalmic Solutions
Travoprost
tafluprost
Prospective Studies
Primary Open Angle Glaucoma
Surveys and Questionnaires

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Nakamura, T., Kanamoto, T., Komatsu, N., Tanito, M., Teranishi, S., Naito, T., ... Kiuchi, Y. (2014). Satisfaction and subjective symptoms after instillation of tafluprost or travoprost for twelve weeks each. Japanese Journal of Clinical Ophthalmology, 68(7), 959-966.

Satisfaction and subjective symptoms after instillation of tafluprost or travoprost for twelve weeks each. / Nakamura, Tomomi; Kanamoto, Takashi; Komatsu, Naoki; Tanito, Masaki; Teranishi, Shinichiro; Naito, Tomoko; Baba, Tetsuya; Hirooka, Kazuyuki; Mizoue, Shiro; Kiuchi, Yoshiaki.

In: Japanese Journal of Clinical Ophthalmology, Vol. 68, No. 7, 2014, p. 959-966.

Research output: Contribution to journalArticle

Nakamura, T, Kanamoto, T, Komatsu, N, Tanito, M, Teranishi, S, Naito, T, Baba, T, Hirooka, K, Mizoue, S & Kiuchi, Y 2014, 'Satisfaction and subjective symptoms after instillation of tafluprost or travoprost for twelve weeks each', Japanese Journal of Clinical Ophthalmology, vol. 68, no. 7, pp. 959-966.
Nakamura, Tomomi ; Kanamoto, Takashi ; Komatsu, Naoki ; Tanito, Masaki ; Teranishi, Shinichiro ; Naito, Tomoko ; Baba, Tetsuya ; Hirooka, Kazuyuki ; Mizoue, Shiro ; Kiuchi, Yoshiaki. / Satisfaction and subjective symptoms after instillation of tafluprost or travoprost for twelve weeks each. In: Japanese Journal of Clinical Ophthalmology. 2014 ; Vol. 68, No. 7. pp. 959-966.
@article{4b050a32b0ca416689af539bb86743b1,
title = "Satisfaction and subjective symptoms after instillation of tafluprost or travoprost for twelve weeks each",
abstract = "Purpose : To report satisfaction and subjective symptoms after instillation of tafluprost followed by travoprost, or vice versa, for 12 weeks each. Cases and Method : This prospective study was made by 29 institutions including 7 universities. We evaluated 174 eyes of 174 cases after eliminating 21 eyes out of 195 cases. The series comprised 71 males and 103 females. The age ranged from 38 to 94 years, average 70 years. There were 167 cases of primary open-angle glaucoma and 7 cases of ocular hypertension. The cases were randomly divided into 2 groups. One group received instillation of 0.0015{\%} tafluprost for 2 weeks and then instillation of 0.004{\%} travoprost for 2 weeks. The other group received travoprost followed by travoprost for 2 weeks each. Satisfaction and subjective symptoms were evaluated by questionnaire. Results : There was no difference in subjective symptoms between tafluprost and travoprost. Tafluprost was significantly preferred over travoprost regarding satisfaction, presumably due to difference in the shape of commercially available ophthalmic solution. Conclusion : No difference was present between tafluprost and travoprost regarding subjective symptoms. Tafluprost was favored by the majority of patients.",
author = "Tomomi Nakamura and Takashi Kanamoto and Naoki Komatsu and Masaki Tanito and Shinichiro Teranishi and Tomoko Naito and Tetsuya Baba and Kazuyuki Hirooka and Shiro Mizoue and Yoshiaki Kiuchi",
year = "2014",
language = "English",
volume = "68",
pages = "959--966",
journal = "Japanese Journal of Clinical Ophthalmology",
issn = "0370-5579",
publisher = "Igaku-Shoin Ltd",
number = "7",

}

TY - JOUR

T1 - Satisfaction and subjective symptoms after instillation of tafluprost or travoprost for twelve weeks each

AU - Nakamura, Tomomi

AU - Kanamoto, Takashi

AU - Komatsu, Naoki

AU - Tanito, Masaki

AU - Teranishi, Shinichiro

AU - Naito, Tomoko

AU - Baba, Tetsuya

AU - Hirooka, Kazuyuki

AU - Mizoue, Shiro

AU - Kiuchi, Yoshiaki

PY - 2014

Y1 - 2014

N2 - Purpose : To report satisfaction and subjective symptoms after instillation of tafluprost followed by travoprost, or vice versa, for 12 weeks each. Cases and Method : This prospective study was made by 29 institutions including 7 universities. We evaluated 174 eyes of 174 cases after eliminating 21 eyes out of 195 cases. The series comprised 71 males and 103 females. The age ranged from 38 to 94 years, average 70 years. There were 167 cases of primary open-angle glaucoma and 7 cases of ocular hypertension. The cases were randomly divided into 2 groups. One group received instillation of 0.0015% tafluprost for 2 weeks and then instillation of 0.004% travoprost for 2 weeks. The other group received travoprost followed by travoprost for 2 weeks each. Satisfaction and subjective symptoms were evaluated by questionnaire. Results : There was no difference in subjective symptoms between tafluprost and travoprost. Tafluprost was significantly preferred over travoprost regarding satisfaction, presumably due to difference in the shape of commercially available ophthalmic solution. Conclusion : No difference was present between tafluprost and travoprost regarding subjective symptoms. Tafluprost was favored by the majority of patients.

AB - Purpose : To report satisfaction and subjective symptoms after instillation of tafluprost followed by travoprost, or vice versa, for 12 weeks each. Cases and Method : This prospective study was made by 29 institutions including 7 universities. We evaluated 174 eyes of 174 cases after eliminating 21 eyes out of 195 cases. The series comprised 71 males and 103 females. The age ranged from 38 to 94 years, average 70 years. There were 167 cases of primary open-angle glaucoma and 7 cases of ocular hypertension. The cases were randomly divided into 2 groups. One group received instillation of 0.0015% tafluprost for 2 weeks and then instillation of 0.004% travoprost for 2 weeks. The other group received travoprost followed by travoprost for 2 weeks each. Satisfaction and subjective symptoms were evaluated by questionnaire. Results : There was no difference in subjective symptoms between tafluprost and travoprost. Tafluprost was significantly preferred over travoprost regarding satisfaction, presumably due to difference in the shape of commercially available ophthalmic solution. Conclusion : No difference was present between tafluprost and travoprost regarding subjective symptoms. Tafluprost was favored by the majority of patients.

UR - http://www.scopus.com/inward/record.url?scp=84903692649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903692649&partnerID=8YFLogxK

M3 - Article

VL - 68

SP - 959

EP - 966

JO - Japanese Journal of Clinical Ophthalmology

JF - Japanese Journal of Clinical Ophthalmology

SN - 0370-5579

IS - 7

ER -